NIH Funding Policy Hurts Young Scientists | Science

The landscape for biomedical research in the United States is undergoing a significant shift, with newly released data revealing a sharp decline in funding success rates at the National Institutes of Health (NIH) in 2025. This downturn, particularly impacting young investigators, stems from a multiyear funding policy initiated by the previous administration, requiring NIH to distribute grants in lump sums covering multiple years. The consequences are already being felt across laboratories nationwide, raising concerns about a potential “brain drain” as researchers consider opportunities abroad.

Funding Rates and the Impact on Early-Career Scientists

Data indicates a substantial drop in the percentage of research grant applications approved by the NIH in 2025. Whereas specific figures vary depending on the institute and research area, the trend is consistent: securing funding is becoming increasingly demanding. Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, highlighted on LinkedIn that the numbers are even more concerning for the National Cancer Institute (NCI) than initially reported. Newsbreak reports that the agency itself acknowledges the disproportionate impact on young investigators. Here’s particularly troubling as these early-career scientists are crucial for driving innovation and ensuring the future of biomedical research.

The shift to multiyear grants, while intended to provide greater financial stability, has inadvertently created bottlenecks and reduced the overall number of projects funded. The AAAS reports that this policy has led to a situation where fewer investigators are receiving funding, and those who do are often established researchers with a track record of success, leaving newer scientists struggling to compete.

Budget Cuts Exacerbate the Problem

Compounding the issue of the funding policy is a proposed $18 billion cut to the NIH’s 2026 federal budget. As reported by the Los Angeles Times, this substantial reduction, representing approximately 40% of the NIH’s 2025 budget, has already resulted in the freezing or termination of thousands of grants. Researchers are facing difficult choices, including shelving experiments, revising career plans, and even contemplating leaving the United States to pursue research opportunities in more stable funding environments.

Stephen Jameson, president of the American Association of Immunologists, warned that this proposal will have both short-term and long-term consequences for the field. The cuts threaten not only ongoing research projects but also key training programs that are essential for developing the next generation of scientists.

Understanding the Multiyear Grant Policy

The policy requiring multiyear grant funding in a single lump sum, implemented during the Trump administration, aimed to streamline the grant process and reduce administrative burdens. Still, it has had unintended consequences. By frontloading funding, the NIH has less flexibility to respond to emerging research priorities or to fund fresh investigators. The policy also creates a competitive disadvantage for early-career researchers who may not have the established track record needed to secure large, multiyear grants.

What Does This Mean for Medical Research?

The combined effect of the funding policy and the proposed budget cuts poses a significant threat to the future of biomedical research in the United States. A reduction in funding will inevitably lead to a slowdown in scientific discovery, potentially delaying the development of new treatments and cures for diseases. The potential “brain drain” – the emigration of talented researchers to other countries – could further weaken U.S. Leadership in global research.

The uncertainty surrounding funding is also creating a climate of anxiety and instability within the scientific community. Researchers are hesitant to embark on long-term projects or to hire new staff, fearing that their funding may be cut short. This can stifle innovation and hinder progress.

Legal Challenges and Advocacy Efforts

The scientific community is actively fighting back against the budget cuts and the negative impacts of the funding policy. Researchers and advocates are pursuing legal challenges, organizing protests, and lobbying policymakers to restore funding to the NIH. The Los Angeles Times reports that at least one court ruling has already forced the reinstatement of some grants, demonstrating the potential for legal action to provide relief.

The Role of Congress

The proposed budget cuts are currently under consideration by Congress. The final outcome will depend on negotiations between lawmakers and the White House. Scientists and advocates are urging Congress to reject the proposed cuts and to invest in biomedical research, recognizing its vital importance to public health and economic growth.

Looking Ahead: Potential Pathways for Resolution

Several potential pathways could address the current crisis in NIH funding. Congress could restore funding to the NIH, mitigating the impact of the proposed budget cuts. The NIH could also revisit the multiyear grant policy, seeking ways to balance the benefits of financial stability with the need to support a diverse range of investigators. Increased public awareness of the challenges facing biomedical research could generate greater support for funding from both the government and private sources.

The situation remains fluid, and the long-term consequences of the current funding challenges are still uncertain. However, a sustained investment in biomedical research is essential for maintaining U.S. Leadership in science and for improving the health and well-being of people around the world. Ongoing monitoring of grant funding rates, coupled with continued advocacy efforts, will be crucial in navigating this challenging period.